PHARMAESSENTIA CORP.
Area: Pharmaceutical and Medical Devices
Booth No:
L118
Website: https://hq.pharmaessentia.com/tw
Exhibitor Profile
Compared with similar drugs on the market, the long-acting, mono-pegylated proline interferon with improved pharmacokinetic properties allowing once every two weeks administration offering improved tolerability and convenience. The marketing authorization for PharmaEssentia’s Ropeginterferon alfa-2b for treatment of Polycythemia Vera (PV) has been granted by EMA, TFDA, US FDA, Korea and Japan.
Brands
Ropeginterferon alfa-2b
Video
-
Improving treatments, improving lives
Exhibit Products
Exhibitors you may be interested in
Highest Rated
-
SUNWAY SCIENTIFIC CORPORATION
-
MINOGA INDUSTRIAL CO., LTD.
-
DEPARTMENT OF LIFE SCIENCES, NATIONAL CHUNG HSING UNIVERSITY
-
PHARMAESSENTIA CORP.
-
NATIONAL TAIWAN UNIVERSITY
-
FORESEE PHARMACEUTICALS CO., LTD.
-
FORMOSA PHARMACEUTICALS , INC
-
TCI CO., LTD.
-
INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
-
MYCOMAGIC BIOTECHNOLOGY CO., LTD.
-
QUARK BIOSCIENCES TAIWAN, INC.
-
GOLDEN BIOTECHNOLOGY CORP.
-
TSH BIOPHARM
-
COLD SPRING BIOTECH CORP.
-
ENERGENESIS BIOMEDICAL CO., LTD.
-
HANCHORBIO INC.
-
ANN TONG INDUSTRIAL CO.,LTD
-
CATCHGENE CO., LTD.
-
DEVELOPMENT CENTER FOR BIOTECHNOLOGY
-
TAIPEI MEDICAL UNIVERSITY
-
LUKAS BIOMEDICAL INC.
-
TAIMED BIOLOGICS INC.
-
AGILENT TECHNOLOGIES TAIWAN LTD.
-
BESTGEN BIOTECH CORP.
-
EFFICIENT PHARMA MANAGEMENT CORP.
-
ADIMMUNE CORPORATION
-
FORMOSA LABORATORIES, INC.
-
OME TECHNOLOGY CO., LTD.
-
BOYEN THERAPEUTICS, INC.
-
ZAX CO., LTD.
back